IBM Retirement Fund’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,393
Closed -$208K 552
2021
Q4
$208K Sell
1,393
-976
-41% -$149K 0.03% 540
2021
Q3
$345K Hold
2,369
0.03% 525
2021
Q2
$464K Buy
2,369
+380
+19% +$68.8K 0.04% 456
2021
Q1
$360K Sell
1,989
-137
-6% -$23.7K 0.03% 555
2020
Q4
$301K Buy
2,126
+275
+15% +$39.9K 0.02% 613
2020
Q3
$231K Buy
+1,851
New +$194K 0.02% 610

Other funds holding TXG

IBM Retirement Fund's TXG Position: Q1 2022 in Review

IBM Retirement Fund sold out of 10x Genomics (TXG) in Q1 2022, closing a stake of 1,393 shares — an estimated $208K sold.

IBM Retirement Fund first reported a position in TXG in Q3 2020 and held it in 6 quarters. The position peaked at $464K in Q2 2021. 314 funds tracked by Wall St. Rank hold TXG as of Q1 2022.

  • IBM Retirement Fund reported no remaining 10x Genomics position as of Q1 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 1,393 10x Genomics shares in Q1 2022, an estimated $208K.
  • IBM Retirement Fund first reported a position in 10x Genomics in Q3 2020 and held it in 6 quarters.
  • IBM Retirement Fund's 10x Genomics position peaked at $464K in Q2 2021.
  • 314 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2022.

Based on IBM Retirement Fund's 13F filing for Q1 2022, filed 14 Apr 2022.